RCEL - Avita Therapeutics, Inc. Common Stock -  [ ]

Seasonality of Returns By Period

Average daily return by calendar bucket (ClosePriceSA).

Day of Week

Week of Month

Month of Year

Seasonal Path

YTD vs Last Year vs Lookback Avg · closes rebased to 100 at each year's first session
Ticker Details
Avita Therapeutics, Inc. Common Stock
IPO Date: October 1, 2019
Sector: Healthcare
Industry: Biotech
Market Cap: $340.81M
Activated in VL: True
Average Daily Range
Avg Daily Range: $0.33 | 3.11%
Avg Daily Range (30 D): $0.43 | 5.45%
Avg Daily Range (90 D): $0.25 | 4.16%
Institutional Daily Volume
Avg Daily Volume: .2M
Avg Daily Volume (30 D): .56M
Avg Daily Volume (90 D): .35M
Trade Size
Avg Trade Size (Sh.): 85
Avg Trade Size (Sh.) (30 D): 71
Avg Trade Size (Sh.) (90 D): 63
Institutional Trades
Total Institutional Trades: 5
Avg Institutional Trade: $1.23M
Avg Institutional Trade (30 D): $.7M
Avg Institutional Trade (90 D): $1.69M
Avg Institutional Trade Volume: .24M
Avg Institutional Trades (Per Day): 1
Market Closing Trades
Avg Closing Trade: $1.69M
Avg Closing Trade (30 D): $.7M
Avg Closing Trade (90 D): $1.69M
Avg Closing Volume: 352.16K
 
News
Aug 7, 2026 @ 12:45 PM
AVITA Medical Announces Participation at Canaccord...
Source: Na
Feb 18, 2026 @ 9:00 AM
Scar Treatment Market Size is Expected to Reach US...
Source: Sns Insider
Jan 25, 2026 @ 10:30 PM
Data at 2026 Boswick Burn & Wound Symposium highli...
Source: Avita Medical, Inc.
Jan 8, 2026 @ 10:00 PM
Bragar Eagel & Squire, P.C. Encourages Soleno, Avi...
Source: Bragar Eagel & Squire, P.C.
Oct 16, 2025 @ 10:15 PM
AVITA Medical Announces CEO Transition
Source: Avita Medical, Inc.
Financials
  TTM Q2 2026 Q1 2026
Basic EPS $-1.43 $-.25 $-.35
Diluted EPS $-1.43 $-.25 $-.35
Revenue $75.63M $21.7M $19.25M
Gross Profit $61.68M $17.77M $15.73M
Net Income / Loss $-43.08M $-7.66M $-10.61M
Operating Income / Loss $-35.22M $-6.86M $-8.8M
Cost of Revenue $13.95M $3.94M $3.52M
Net Cash Flow $-30.47M $.83M $-1.93M
PE Ratio